| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.05. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 24.04. | iTonic Holdings (ITOC) Stock Surges Over 66% After Hours: Why Is It Moving? | 1 | Benzinga.com | ||
| 23.04. | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | 212 | GlobeNewswire (Europe) | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen | |
| 23.04. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 24.03. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| ITONIC Aktie jetzt für 0€ handeln | |||||
| 26.01. | iTonic Holdings Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 13.01. | Pheton Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 13.01. | Pheton Holdings to change name to iTonic, ticker to ITOC | 2 | Seeking Alpha | ||
| 13.01. | Pheton Holdings Ltd. Announces Corporate Name Change and Stock Ticker Symbol Change | 1.365 | GlobeNewswire (Europe) | BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen | |
| 16.12.25 | Pheton Holdings Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 05.12.25 | Pheton Holdings schließt Übernahme von 51 % an KI-Gesundheitsunternehmen iTonic ab | 5 | Investing.com Deutsch | ||
| 05.12.25 | Pheton Holdings completes acquisition of 51% stake in iTonic | 1 | Investing.com | ||
| 05.12.25 | Pheton Holdings Ltd. Announces Closing of Share Acquisition with iTonic | 464 | GlobeNewswire (Europe) | Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) ("Pheton" or the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy... ► Artikel lesen | |
| 05.12.25 | Pheton Holdings Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 23.10.25 | Pheton Holdings Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency | 750 | GlobeNewswire (Europe) | Beijing, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ: PTHL) (the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and... ► Artikel lesen | |
| 01.08.25 | Pheton Holdings Ltd. Issues Statements Addressing Recent Market Activity and Misleading Rumors | 710 | GlobeNewswire (Europe) | BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company," "we," "our" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 4,805 | -1,84 % | Plus Therapeutics Inc.: Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases | ||
| ORGANON | 11,445 | -0,48 % | Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia | SEOUL, South Korea, May 21, 2026 (GLOBE NEWSWIRE) -- Hanmi Pharmaceutical announced that it has signed a supply agreement with global healthcare company Organon to export three combination medicines... ► Artikel lesen | |
| CO-DIAGNOSTICS | 7,210 | -15,47 % | Is Co-Diagnostics National Security's Next Diagnostic Pick? | ||
| SENSEONICS | 5,800 | -1,69 % | Senseonics Holdings, Inc.: Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026 | ||
| VIRIDIAN THERAPEUTICS | 14,700 | +0,68 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
| INSPIRE MEDICAL SYSTEMS | 35,000 | -0,57 % | What Does Stifel Think About Inspire Medical (INSP) After a Guidance Cut That Surprised Wall Street? | ||
| VYOME | 2,320 | -0,85 % | Vyome Holdings, Inc. reports Q1 results | ||
| EMBECTA | 2,885 | +1,84 % | Dividendenbekanntmachungen (28.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACTIVIA PROPERTIES INC JP3047490002 3169 JPY 17,0809 EUR ADVANCED MEDICAL SOLUTIONS GROUP PLC GB0004536594 0,0201 GBP 0,0232 EUR AIA... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,630 | +1,14 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| AXOGEN | 33,390 | +0,24 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 21,760 | +5,53 % | Tactile Systems Technology, Inc.: Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio | MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| APYX MEDICAL | 3,320 | -1,19 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| GLAUKOS | 89,50 | +0,56 % | Glaukos - GKOS: Pullback-Setup mit Unterstützung bei 130 USD! | Starkes Wachstum erwartet! Aber Achtung: Insider verkaufen Glaukos-Aktien (GKOS) im Wert von 4.2 Millionen USD! Glaukos (GKOS) - US3773221029 Rückblick: Aufgrund der stark überkauften Situation am US-Gesamtmarkt... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,620 | +2,99 % | Lexaria Bioscience Corp.: Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 | KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, is pleased to announce that ethics... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,160 | -2,77 % | Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | MELBOURNE, Australia and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for... ► Artikel lesen |